943722-02-9

Basic information

• Product Name: (3-bromo-2-methylphenyl)methanamine
• Synonyms: (3-bromo-2-methylphenyl)methanamine;3-BroMo-2-MethylbenzeneMethanaMine;(3-bromo-2-methy1lphenyl)methanamine
• CAS NO: 943722-02-9
• Molecular Formula: C₈H₁₀BrN
• Molecular Weight: 200.0757
• Mol File: 943722-02-9.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: (3-bromo-2-methylphenyl)methanamine(CAS DataBase Reference)
• NIST Chemistry Reference: (3-bromo-2-methylphenyl)methanamine(943722-02-9)
• EPA Substance Registry System: (3-bromo-2-methylphenyl)methanamine(943722-02-9)

Safety Data

• Hazardous Substances Data: 943722-02-9(Hazardous Substances Data)

Usage

General Description

(3-bromo-2-methylphenyl)methanamine, also known as 4-Bromo-2-methylbenzylamine, is a chemical compound with the molecular formula C8H10BrN. It is an aromatic amine and is used in organic synthesis, specifically in the production of pharmaceuticals, agrochemicals, and other fine chemicals. It is a white solid that is soluble in organic solvents and has a distinct aromatic odor. (3-bromo-2-methylphenyl)methanamine is a versatile compound that is often utilized as a building block in the synthesis of various biologically active molecules and has potential applications in the pharmaceutical and agrochemical industries.

Upstream product

• 919363-09-0 3-bromo-2-methylbenzamide 

Downstream Products

• 1177558-64-3 tert-butyl N-[(3-bromo-2-methylphenyl)methyl]carbamate 
• 1236107-83-7 4-{[2-(3-bromo-2-methyl-benzylamino)-5-nitro-pyrimidin-4-ylamino]-methyl}-piperidine-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

Dual Pharmacophores - PDE4-Muscarinic Antagonistics

The present invention is directed to novel compounds of Formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions and their use as dual chromaphores having inhibitory activity against PDE4 and muscarinic acetylcholine receptors (mAChRs), and thus being useful for treating respiratory diseases.

Dual Pharmacophores - PDE4-Muscarinic Antagonistics

The present invention is directed to novel compounds of Formula (I), pharmaceutical compositions and their use in therapy, for example as inhibitors of phosphodiesterase type IV (PDE4) and as antagonists of muscarinic acetylcholine receptors (mAChRs), in the treatment of/and or prophylaxis of respiratory diseases, including antiinflammatory and/or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rhinitis (e.g. allergic rhinitis), atopic dermatitis or psoriasis.